| ²é¿´: 511 | »Ø¸´: 1 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
Öò¹âÀïµÄ΢Цгæ (ÕýʽдÊÖ)
|
[½»Á÷]
ÇóÖú£ºÒ»¾ä»°·Òë
|
||
| ·ÖÎöĿǰ¼×°±µûßÊѪҩŨ¶È²â¶¨µÄ·½·¨£¬Ñ°ÕÒ×ʹÓõķÖÎö·½·¨¼°Óë¸Ã·½·¨Ïà¶ÔÓ¦µÄ·ÖÎöÌõ¼þ£¬ÎªTDxFLx/TDxÃâÒß·ÖÎöÒÇÅäÌ×ÊÔ¼ÁºÐÍ£²úºóÌṩ¿É¹©Ñ¡ÔñµÄ¼×°±µûßÊѪҩŨ¶È²â¶¨·½·¨¡£ |
» ²ÂÄãϲ»¶
22408µ÷¼Á315·Ö
ÒѾÓÐ3È˻ظ´
²ÄÁÏ¿¼Ñе÷¼Á
ÒѾÓÐ26È˻ظ´
»¯¹¤µ÷¼ÁÇóµ¼Ê¦ÊÕÁô£¡Ò»Ö¾Ô¸Ê§Àû£¬Ì¤Êµ¿Ï¸É£¬ÓÐÖ²ÎïÌáÈ¡¿ÆÑоÀú
ÒѾÓÐ21È˻ظ´
290Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
ҩѧ305Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
¸´ÊÔµ÷¼Á
ÒѾÓÐ6È˻ظ´
0831Ò»ÂÖµ÷¼Áʧ°ÜÇóÖú
ÒѾÓÐ6È˻ظ´
ÇóÖúµ÷¼Á£¬¿çµ÷
ÒѾÓÐ11È˻ظ´
291Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
272·Ö²ÄÁÏ×ÓÇóµ÷¼Á
ÒѾÓÐ45È˻ظ´
zerohead
½û³æ (Ö°Òµ×÷¼Ò)
- ·ÒëEPI: 466
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ¹ó±ö: 0.301
- ½ð±Ò: 8727.8
- É¢½ð: 850
- ºì»¨: 15
- ɳ·¢: 10
- Ìû×Ó: 3768
- ÔÚÏß: 471.7Сʱ
- ³æºÅ: 1041741
- ×¢²á: 2010-06-14
- ÐÔ±ð: GG
- רҵ: Â߼ѧ
Öò¹âÀïµÄ΢Ц(½ð±Ò+3, ·ÒëEPI+1): 2010-08-12 15:27:13
|
Ä¿µÄ ·ÖÎöĿǰ¼×°±µûßÊѪҩŨ¶È²â¶¨µÄ·½·¨£¬Ñ°ÕÒ×ʹÓõķÖÎö·½·¨¼°Óë¸Ã·½·¨Ïà¶ÔÓ¦µÄ·ÖÎöÌõ¼þ£¬ÎªTDxFLx/TDxÃâÒß·ÖÎöÒÇÅäÌ×ÊÔ¼ÁºÐÍ£²úºóÌṩ¿É¹©Ñ¡ÔñµÄ¼×°±µûßÊѪҩŨ¶È²â¶¨·½·¨¡£ Objectives: To evaluate the currently used methods for determining blood concentration of methotrexate, and find out the most frequently used analytical method and the corresponding testing conditions. To provide another choice of determining blood concentration of methotrexate after the termination of reagent production for the TDxFLx/TDx immunoassay. |
2Â¥2010-08-12 15:22:35













»Ø¸´´ËÂ¥
5